C–X–C ligand 10 and C–X–C receptor 3 status can predict tamoxifen treatment response in breast cancer patients

Deregulation of HER2 Downstream Signaling in Breast Cancer Cells by a Cocktail of Anti-HER2 scFvs

(2013) Foroogh Nejatollahi et al.   ONCOLOGY RESEARCH

Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells

(2012) Keiko Kajitani et al.   BREAST CANCER RESEARCH AND TREATMENT

Tumoral Lymphocytic Infiltration and Expression of the Chemokine CXCL10 in Breast Cancers from the Ontario Familial Breast Cancer Registry

(2012) A. M. Mulligan et al.   CLINICAL CANCER RESEARCH

Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion

(2012) Qian Wu et al.   Molecular Cancer

Immunity and autoimmunity: revising the concepts of response to breast cancer

(2011) Giuseppe Curigliano   BREAST

CXCR3 ligands: redundant, collaborative and antagonistic functions

(2011) Joanna R Groom et al.   IMMUNOLOGY AND CELL BIOLOGY

CXCR3/Ligands Are Significantly Involved in the Tumorigenesis of Basal Cell Carcinomas

(2010) Blanche Ka Ki Lo et al.   AMERICAN JOURNAL OF PATHOLOGY

CXCR3-B Can Mediate Growth-inhibitory Signals in Human Renal Cancer Cells by Down-regulating the Expression of Heme Oxygenase-1

(2010) Dipak Datta et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Organ-specific inhibition of metastatic colon carcinoma by CXCR3 antagonism

(2009) B Cambien et al.   BRITISH JOURNAL OF CANCER

Tamoxifen Induces Expression of Immune Response-Related Genes in Cultured Normal Human Mammary Epithelial Cells

(2009) L. J. Schild-Hay et al.   CANCER RESEARCH

Interferon-α counteracts the angiogenic switch and reduces tumor cell proliferation in a spontaneous model of prostatic cancer

(2009) Luca Persano et al.   CARCINOGENESIS

Ratio of 17HSD1 to 17HSD2 Protein Expression Predicts the Outcome of Tamoxifen Treatment in Postmenopausal Breast Cancer Patients

(2009) A. Jansson et al.   CLINICAL CANCER RESEARCH

CXCR3 expression is associated with poor survival in breast cancer and promotes metastasis in a murine model

(2009) X. Ma et al.   MOLECULAR CANCER THERAPEUTICS

Antitumor/Antiestrogenic Effect of the Chemokine Interferon Inducible Protein 10 (IP-10) Involves Suppression of VEGF Expression in Mammary Tissue

(2008) Susan M. Aronica et al.   JOURNAL OF INTERFERON AND CYTOKINE RESEARCH

CXCR3-B Expression Correlates With Tumor Necrosis Extension in Renal Cell Carcinoma

(2008) Mauro Gacci et al.   JOURNAL OF UROLOGY